StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
10
This year
1
Publishing Date
2024 - 01 - 04
1
2023 - 11 - 21
1
2023 - 04 - 14
1
2023 - 02 - 11
1
2022 - 11 - 28
1
2022 - 11 - 10
1
2022 - 06 - 27
1
2022 - 04 - 06
1
2022 - 03 - 25
1
2021 - 04 - 21
1
Sector
Health technology
10
N/a
1
Tags
Agreement
12
Alliances
24
America
28
Antibody
19
Astrazeneca
16
Biotech
28
Breast
11
Breast cancer
13
Cancer
144
Cell
14
Clinical-trials-phase-iii
16
Collaboration
14
Covid-19
8
Diabetes
16
Diagnostic
10
Diagnostics
11
Disease
34
Drug
70
Drug delivery
12
Enhertu
24
Europe
11
Expected
13
Fda
9
Financial
10
Financial results
9
Global
108
Granted
8
Growing
24
Growth
120
Health
9
Her2
27
Her2-
18
Immunotherapy
10
Iot
8
Key
9
License
16
Liver
18
Lung
24
Lung cancer
10
Market
267
Metastatic breast cancer
11
N/a
516
Partnership
8
People
10
Pharma
10
Positive
13
Reach
20
Report
95
Research
73
Respiratory
12
Results
30
Review
11
Set
16
System
9
Technology
10
Therapeutics
71
Therapy
32
Treatment
46
Trial
52
Vaccine
29
Entities
Abbvie inc.
1
Adaptimmune therapeutics plc
1
Amgen inc.
3
Astrazeneca plc
10
Atara biotherapeutics, inc.
1
Bristol-myers squibb company
6
Celyad oncology sa
1
Eli lilly and company
5
Gilead sciences, inc.
1
Glaxosmithkline plc
5
Inovio pharmaceuticals, inc.
1
Iovance biotherapeutics, inc.
1
Johnson & johnson
3
Novartis ag
7
Pfizer, inc.
1
Sanofi
4
Spectrum pharmaceuticals, inc.
1
Symbols
ALLO
4
ALZN
4
AMGN
4
ATNM
5
AZN
10
AZNCF
8
BCTX
10
BMY
17
BNTX
9
CADL
5
CGEN
6
CLLS
5
CRSP
4
CTXR
4
CUE
6
EVAX
5
FATE
10
FNCTF
5
GALT
4
GH
4
GILD
5
GLAXF
5
GSK
7
GTBP
4
HOOK
4
HOWL
5
IMUN
4
INO
4
IOVA
10
JNJ
12
KA
5
LIXT
4
LLY
11
MDNA
9
NAVB
4
NBTX
4
NKTR
6
NVS
12
NVSEF
11
NXTC
5
OCEA
7
OCX
4
ONCR
8
PGEN
9
PHIO
9
PVCT
9
REGN
6
REPL
5
RGBP
4
RNAZ
5
SCPS
5
SGEN
5
SNSE
8
SNY
31
SNYNF
25
SQZ
5
SURF
4
TAK
4
TCRX
4
TSOI
5
Exchanges
Nasdaq
10
Nyse
9
Crawled Date
2024 - 01 - 04
1
2023 - 11 - 21
1
2023 - 04 - 14
1
2023 - 02 - 11
1
2022 - 11 - 28
1
2022 - 11 - 10
1
2022 - 06 - 27
1
2022 - 04 - 06
1
2022 - 03 - 25
1
2021 - 04 - 21
1
Crawled Time
08:00
1
12:00
1
16:00
1
16:20
1
17:00
2
18:00
1
19:00
1
23:00
2
Source
www.prnewswire.com
10
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Immunotherapy
symbols :
Azn
save search
Cancer Immunotherapy Market to grow by USD 38.57 billion from 2022 to 2027, North America to account for 41% of market growth- Technavio
Published:
2024-01-04
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
1.69%
|
O:
2.46%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-7.71%
|
O:
0.49%
H:
0.6%
C:
-0.83%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
-1.24%
|
O:
0.15%
H:
1.88%
C:
-1.17%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-8.57%
|
O:
-0.24%
H:
1.43%
C:
1.43%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-6.84%
|
O:
0.32%
H:
0.93%
C:
0.38%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
4.58%
|
O:
-0.36%
H:
0.98%
C:
0.72%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-6.99%
|
O:
-0.14%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
3.52%
|
O:
-0.68%
H:
0.87%
C:
0.1%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
-9.95%
|
O:
-0.32%
H:
0.44%
C:
0.26%
america
cancer
immunotherapy
market
Locally Advanced Pancreatic Cancer Market Report 2023-2028: Recent Advancements in Immunotherapy Inject New Hope into LAPC Market
Published:
2023-11-21
(Crawled : 23:00)
- prnewswire.com
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
7.73%
|
O:
0.76%
H:
0.0%
C:
-0.05%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
0.78%
|
O:
0.56%
H:
1.53%
C:
1.37%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
10.77%
|
O:
-0.89%
H:
0.33%
C:
-0.16%
report
hope
cancer
pancreatic
immunotherapy
market
New analysis of Phase II data at AACR assesses ImaginAb's investigational CD8 ImmunoPET technology's ability to predict response in immunotherapy
Published:
2023-04-14
(Crawled : 08:00)
- prnewswire.com
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
-4.77%
|
O:
-0.59%
H:
0.18%
C:
-0.63%
immunotherapy
response
Global Immunotherapy Drugs Market Report to 2028 - Players Include F. Hoffmann-La Roche, GSK, Merck & Co, Pfizer and Sanofi
Published:
2023-02-11
(Crawled : 16:20)
- prnewswire.com
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
Email alert
Add to watchlist
global
immunotherapy
report
sanofi
market
Global Immuno-oncology Market Report to 2028: An Increase in the Research and Development in Cancer Immunotherapy Will Be Driving Growth
Published:
2022-11-28
(Crawled : 12:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
19.54%
|
O:
0.57%
H:
0.0%
C:
-2.51%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
1.58%
|
O:
-0.38%
H:
1.09%
C:
0.87%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
32.41%
|
O:
1.03%
H:
0.0%
C:
-0.68%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
12.13%
|
O:
0.29%
H:
0.45%
C:
-0.32%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
20.21%
|
O:
-0.65%
H:
0.83%
C:
-0.03%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
105.94%
|
O:
-0.49%
H:
1.67%
C:
0.64%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
7.6%
|
O:
0.12%
H:
0.97%
C:
-0.06%
research
global
immunotherapy
report
cancer
growth
market
Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published:
2022-11-10
(Crawled : 17:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
27.65%
|
O:
-0.06%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
12.32%
|
O:
6.22%
H:
3.13%
C:
-0.56%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
18.54%
|
O:
2.81%
H:
0.43%
C:
-0.2%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-14.94%
|
O:
0.18%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
26.03%
|
O:
2.59%
H:
0.72%
C:
0.63%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-38.76%
|
O:
1.22%
H:
0.01%
C:
-1.7%
IOVA
4
|
$11.69
-1.43%
-1.45%
2.7M
|
Health Technology
|
49.36%
|
O:
6.12%
H:
4.99%
C:
4.21%
INO
|
$10.1
-2.6%
-2.67%
250K
|
Health Technology
|
366.06%
|
O:
5.5%
H:
4.35%
C:
3.48%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-18.51%
|
O:
1.43%
H:
0.36%
C:
-1.08%
ATRA
|
$0.7101
-1.18%
-1.2%
700K
|
Health Technology
|
-81.7%
|
O:
2.58%
H:
23.12%
C:
20.85%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
16.63%
|
O:
7.08%
H:
0.84%
C:
-0.43%
ADAP
|
$1.085
-4.83%
-5.07%
780K
|
Health Technology
|
-48.57%
|
O:
0.0%
H:
7.14%
C:
5.71%
covid-19
research
global
immunotherapy
report
impact
technology
market
Cancer Immunotherapy Market Expands with Rising Adoption of Target Therapy in Cancer Treatment, States TMR Report
Published:
2022-06-27
(Crawled : 16:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
-24.74%
|
O:
0.47%
H:
3.73%
C:
3.73%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-10.05%
|
O:
4.15%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
4.75%
|
O:
-1.55%
H:
4.43%
C:
0.03%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-48.23%
|
O:
1.46%
H:
1.45%
C:
0.78%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
17.74%
|
O:
1.86%
H:
1.05%
C:
0.24%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
-25.18%
|
O:
-0.16%
H:
0.61%
C:
0.18%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
135.52%
|
O:
1.32%
H:
0.0%
C:
0.0%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-38.12%
|
O:
0.34%
H:
1.72%
C:
0.95%
SPPI
|
$1.03
-0.97%
0
|
Health Technology
|
17.05%
|
O:
0.0%
H:
2.28%
C:
-2.27%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-9.51%
|
O:
0.53%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
7.07%
|
O:
-0.36%
H:
1.22%
C:
0.38%
immunotherapy
report
therapy
cancer
market
treatment
Global Cancer Immunotherapy Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published:
2022-04-06
(Crawled : 19:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
-9.28%
|
O:
0.23%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-11.49%
|
O:
4.21%
H:
0.0%
C:
-0.61%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
-1.65%
|
O:
1.45%
H:
0.46%
C:
0.19%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
7.8%
|
O:
1.98%
H:
0.0%
C:
-1.11%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
8.49%
|
O:
0.39%
H:
0.53%
C:
0.44%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-17.38%
|
O:
1.15%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
-9.19%
|
O:
1.01%
H:
0.0%
C:
0.0%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
145.95%
|
O:
-0.27%
H:
2.95%
C:
1.12%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-35.15%
|
O:
0.05%
H:
2.52%
C:
2.49%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-11.02%
|
O:
1.74%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
3.08%
|
O:
0.35%
H:
2.64%
C:
2.45%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
9.23%
|
O:
-0.29%
H:
1.42%
C:
0.98%
immunotherapy
cancer
market
Drugs for Immunotherapy Global Market Report 2022
Published:
2022-03-25
(Crawled : 18:00)
- prnewswire.com
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
1.07%
|
O:
-6.55%
H:
7.81%
C:
7.56%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
14.41%
|
O:
1.14%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-15.13%
|
O:
0.65%
H:
0.0%
C:
0.0%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
161.47%
|
O:
0.28%
H:
1.09%
C:
0.18%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
7.85%
|
O:
-1.58%
H:
1.16%
C:
0.23%
immunotherapy
report
market
drug
Global Leukemia Therapeutics Markets, 2016-2020 & 2021-2026 - Chemotherapy, Stem Cell Transplantation, Immunotherapy, Targeted Therapy, & Others
Published:
2021-04-21
(Crawled : 17:00)
- prnewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
11.98%
|
O:
0.56%
H:
0.72%
C:
0.38%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
294.63%
|
O:
0.5%
H:
0.76%
C:
-0.32%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-26.06%
|
O:
0.67%
H:
0.56%
C:
-0.3%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
53.9%
|
O:
0.7%
H:
1.5%
C:
0.92%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
36.22%
|
O:
1.24%
H:
0.48%
C:
0.36%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
5.35%
|
O:
0.49%
H:
0.23%
C:
-0.63%
immunotherapy
stem cell
therapy
leukemia
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.